Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 2Phase 1 1

Status

Unknown 9Completed 6Recruiting 5Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 1Gastric Cancer Stage 1

Interventions

Capecitabine 25Oxaliplatin 24Paclitaxel 23Gemcitabine 21Cisplatin 21Fluorouracil 20Carboplatin 18Drug Therapy 17Docetaxel 17pembrolizumab 15Leucovorin 15Irinotecan 15Radiotherapy 12tislelizumab 11Injections 10Radiation 9Pemetrexed 9Magnetic Resonance Spectroscopy 9Bevacizumab 9toripalimab 8Cetuximab 8Surgical Procedures, Operative 7Specimen Handling 7Radiotherapy, Intensity-Modulated 7Azacitidine 7venetoclax 6sintilimab 6atezolizumab 6Topotecan 6Cyclophosphamide 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × XELOX × Clear all
NCT07132463 2025-08-20

Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study

Fudan University

Phase 3 Not yet recruiting
154 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07068516 2025-07-16

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Zhejiang Cancer Hospital

Phase 3 Not yet recruiting
470 enrolled
Gastrointestinal

Gastric Cancer Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡